Brooks Macdonald Group PLC Director appointment (0700Q)

TIDMBRK

RNS Number : 0700Q

Brooks Macdonald Group PLC

16 February 2023

BROOKS MACDONALD GROUP PLC

Director appointment

Brooks Macdonald Group plc ("The Group", "Brooks Macdonald") is pleased to announce the appointment of James Rawlingson as Non-Executive Director effective 2 March 2023. James will in due course assume the role of Chairman of the Audit Committee, subject to regulatory approval.

James currently serves as Chairman of the Audit and Risk Committee at Citibank UK, Chairman of the Audit and Risk Assurance Committee at the Foreign Office's executive agency Wilton Park, and Chairman of the Board at Novai Ltd. In his executive career James has held senior positions at Coutts, UBS Wealth, Charles Stanley plc and Arix Bioscience plc.

Commenting on the appointment, Acting Chairman Richard Price said: "I am delighted that James is joining the Board. James has had an extensive career and his sector experience will provide valuable insight as the Company continues towards its strategic goals."

AIM disclosures

During the five years immediately preceding the date of this announcement, James Hedley Rawlingson, who is 55 years old, held the following directorships:

Current

Citibank UK Limited

Wilton Park (an Arm's Length Body of the British Foreign, Commonwealth & Development Office)

Novai Limited

Next Gen PPE limited

Arix Bioscience Holdings Limited

Arix Bioscience plc

Arthurian Life Sciences GP Limited

Als SPV Limited

Arix Capital Management Limited

Arthurian Life Sciences SPV GP Limited

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

Enquiries to:

Brooks Macdonald Group plc

Andrew Shepherd, CEO

www.brooksmacdonald.com

020 7927 4816

Peel Hunt LLP (Nominated Adviser and Broker)

Paul Shackleton / Andrew Buchanan / John Welch

020 7418 8900

FTI Consulting

Laura Ewart / Katherine Bell

brooksmacdonald@fticonsulting.com

07711 387 085 / 07976 870 961

Notes to editors

Brooks Macdonald Group plc, through its various subsidiaries, provides leading investment management services in the UK and internationally. The Group, which was founded in 1991 and began trading on AIM in 2005, had discretionary Funds under Management of GBP16.2 billion as at 31 December 2022.

Brooks Macdonald offers a range of investment management services to private high net worth individuals, pension funds, institutions, charities and trusts. The Group also provides financial planning as well as international investment management, and acts as fund manager to a range of onshore and international funds.

The Group has fifteen offices across the UK and Crown Dependencies including London, Birmingham, Cheltenham, East Anglia, Exeter, Leeds, Manchester, Nuneaton, Southampton, Tunbridge Wells, Scotland, Wales, Jersey, Guernsey and Isle of Man.

LEI: 213800WRDF8LB8MIEX37

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUVSWROAUUAAR

(END) Dow Jones Newswires

February 16, 2023 02:00 ET (07:00 GMT)

Grafico Azioni Brooks (AQSE:BRK.GB)
Storico
Da Gen 2025 a Feb 2025